{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T12:50:45Z","timestamp":1768999845112,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2017\/25\/B\/NZ2\/00414"],"award-info":[{"award-number":["2017\/25\/B\/NZ2\/00414"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:p>Mucopolysaccharidoses (MPS) are a group of lysosomal storage diseases (LSD) caused by mutations in genes coding for enzymes responsible for degradation of glycosaminoglycans (GAGs). Most types of these severe disorders are characterized by neuronopathic phenotypes. Although lysosomal accumulation of GAGs is the primary metabolic defect in MPS, secondary alterations in biochemical processes are considerable and influence the course of the disease. Early hypothesis suggested that these secondary changes might be due to lysosomal storage-mediated impairment of activities of other enzymes, and subsequent accumulation of various compounds in cells. However, recent studies indicated that expression of hundreds of genes is changed in MPS cells. Therefore, we asked whether metabolic effects observed in MPS are caused primarily by GAG-mediated inhibition of specific biochemical reactions or appear as results of dysregulation of expression of genes coding for proteins involved in metabolic processes. Transcriptomic analyses of 11 types of MPS (using RNA isolated from patient-derived fibroblasts), performed in this study, showed that a battery of the above mentioned genes is dysregulated in MPS cells. Some biochemical pathways might be especially affected by changes in expression of many genes, including GAG metabolism and sphingolipid metabolism which is especially interesting as secondary accumulation of various sphingolipids is one of the best known additional (while significantly enhancing neuropathological effects) metabolic defects in MPS. We conclude that severe metabolic disturbances, observed in MPS cells, can partially arise from changes in the expression of many genes coding for proteins involved in metabolic processes.<\/jats:p>","DOI":"10.1007\/s11011-023-01231-5","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T10:03:38Z","timestamp":1684317818000},"page":"2133-2144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dysregulation of genes coding for proteins involved in metabolic processes in mucopolysaccharidoses, evidenced by a transcriptomic approach"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3634-6567","authenticated-orcid":false,"given":"Karolina","family":"Pierzynowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrycja","family":"Deresz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4042-7466","authenticated-orcid":false,"given":"Grzegorz","family":"W\u0119grzyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0820-7204","authenticated-orcid":false,"given":"Lidia","family":"Gaffke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,17]]},"reference":[{"key":"1231_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ymgme.2019.04.007","volume":"128","author":"S Anheuser","year":"2019","unstructured":"Anheuser S, Breiden B, Sandhoff K (2019) Ganglioside GM2 catabolism is inhibited by storage compounds of mucopolysaccharidoses and by cationic amphiphilic drugs. Mol Genet Metabol 128:75\u201383. https:\/\/doi.org\/10.1016\/j.ymgme.2019.04.007","journal-title":"Mol Genet Metabol"},{"key":"1231_CR2","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.3390\/ijms21072566","volume":"21","author":"B Breiden","year":"2020","unstructured":"Breiden B, Sandhoff K (2020) Mechanism of secondary ganglioside and lipid accumulation in lysosomal disease. Int J Mol Sci 21:2566. https:\/\/doi.org\/10.3390\/ijms21072566","journal-title":"Int J Mol Sci"},{"key":"1231_CR3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/cbin.11332","volume":"45","author":"J Brokowska","year":"2021","unstructured":"Brokowska J, Pierzynowska K, Gaffke L, Rintz E, W\u0119grzyn G (2021) Expression of genes involved in apoptosis is dysregulated in mucopolysaccharidoses as revealed by pilot transcriptomic analyses. Cell Biol Int 45:549\u2013557. https:\/\/doi.org\/10.1002\/cbin.11332","journal-title":"Cell Biol Int"},{"key":"1231_CR4","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.3389\/fimmu.2018.02316","volume":"9","author":"C Brosseau","year":"2018","unstructured":"Brosseau C, Colas L, Magnan A, Brouard S (2018) CD9 tetraspanin: A new pathway for the regulation of inflammation? Front Immunol 9:2316. https:\/\/doi.org\/10.3389\/fimmu.2018.02316","journal-title":"Front Immunol"},{"key":"1231_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3390\/genes13040593","volume":"13","author":"Z Cyske","year":"2022","unstructured":"Cyske Z, Gaffke L, Pierzynowska K, W\u0119grzyn G (2022) Complex changes in the efficiency of the expression of many genes in monogenic diseases, mucopolysaccharidoses, may arise from significant disturbances in the levels of factors involved in the gene expression regulation processes. Genes 13:593. https:\/\/doi.org\/10.3390\/genes13040593","journal-title":"Genes"},{"key":"1231_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/genes14020271","volume":"14","author":"Z Cyske","year":"2023","unstructured":"Cyske Z, Gaffke L, Pierzynowska K, W\u0119grzyn G (2023) Expression of long noncoding RNAs in fibroblasts from mucopolysaccharidosis patients. Genes 14:271. https:\/\/doi.org\/10.3390\/genes14020271","journal-title":"Genes"},{"key":"1231_CR7","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3390\/biomedicines11030810","volume":"11","author":"A David","year":"2023","unstructured":"David A, Chazeirat T, Saidi A, Lalmanach G, Lecaille F (2023) The interplay of glycosaminoglycans and cysteine cathepsins in mucopolysaccharidosis. Biomedicines 11:810. https:\/\/doi.org\/10.3390\/biomedicines11030810","journal-title":"Biomedicines"},{"key":"1231_CR8","doi-asserted-by":"publisher","unstructured":"Dorfman A, Matalon R (1976) The mucopolysaccharidoses (a review). Proc Natl Acad Sci U S A 73:630\u2013637. https:\/\/doi.org\/10.1073\/pnas.73.2.630","DOI":"10.1073\/pnas.73.2.630"},{"key":"1231_CR9","doi-asserted-by":"publisher","first-page":"22029","DOI":"10.1074\/jbc.M109.002840","volume":"284","author":"C Faye","year":"2009","unstructured":"Faye C, Moreau C, Chautard E, Jetne R, Fukai N, Ruggiero F, Humphries MJ, Olsen BR, Ricard-Blum S (2009) Molecular interplay between endostatin, integrins, and heparan sulfate. J Biol Chem 284:22029\u201322040. https:\/\/doi.org\/10.1074\/jbc.M109.002840","journal-title":"J Biol Chem"},{"key":"1231_CR10","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.3390\/ijms21072515","volume":"21","author":"S Fecarotta","year":"2020","unstructured":"Fecarotta S, Tarallo A, Damiano C, Minopoli N, Parenti G (2020) Pathogenesis of mucopolysaccharidoses, an update. Int J Mol Sci 21:2515. https:\/\/doi.org\/10.3390\/ijms21072515","journal-title":"Int J Mol Sci"},{"key":"1231_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fnins.2019.00164","volume":"13","author":"EM Foster","year":"2019","unstructured":"Foster EM, Dangla-Valls A, Lovestone S, Ribe EM, Buckley NJ (2019) Clusterin in Alzheimer\u2019s disease: Mechanisms, genetics, and lessons from other pathologies. Front Neurosci 13:164. https:\/\/doi.org\/10.3389\/fnins.2019.00164","journal-title":"Front Neurosci"},{"key":"1231_CR12","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s11011-017-0009-1","volume":"32","author":"H Fu","year":"2017","unstructured":"Fu H, Meadows AS, Pineda RJ, Mohney RP, Stirdivant S, McCarty DM (2017) Serum global metabolomics profiling reveals profound metabolic impairments in patients with MPS IIIA and MPS IIIB. Metab Brain Dis 32:1403\u20131415. https:\/\/doi.org\/10.1007\/s11011-017-0009-1","journal-title":"Metab Brain Dis"},{"key":"1231_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11275","author":"L Gaffke","year":"2019","unstructured":"Gaffke L, Pierzynowska K, Podlacha M, Brokowska J, W\u0119grzyn G (2019) Changes in cellular processes occurring in mucopolysaccharidoses as underestimated pathomechanisms of these diseases. Cell Biol Int. https:\/\/doi.org\/10.1002\/cbin.11275. (in Press)","journal-title":"Cell Biol Int"},{"key":"1231_CR14","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3390\/ijms21041204","volume":"21","author":"L Gaffke","year":"2020","unstructured":"Gaffke L, Pierzynowska K, Podlacha M, Hoinkis D, Rintz E, Brokowska J, Cyske Z, Wegrzyn G (2020) Underestimated aspect of mucopolysaccharidosis pathogenesis: global changes in cellular processes revealed by transcriptomic studies. Int J Mol Sci 21:1204. https:\/\/doi.org\/10.3390\/ijms21041204","journal-title":"Int J Mol Sci"},{"key":"1231_CR15","doi-asserted-by":"publisher","first-page":"E344","DOI":"10.3390\/jcm9020344","volume":"9","author":"R Heon-Roberts","year":"2020","unstructured":"Heon-Roberts R, Nguyen A, Pshezhetsky AV (2020) Molecular bases of neurodegeneration and cognitive decline, the major burden of Sanfilippo disease. J Clin Med 9:E344. https:\/\/doi.org\/10.3390\/jcm9020344","journal-title":"J Clin Med"},{"key":"1231_CR16","first-page":"116","volume":"114","author":"TE Kelly","year":"1976","unstructured":"Kelly TE (1976) The mucopolysaccharidoses and mucolipidoses. Clin Orthop Relat Res 114:116\u2013133","journal-title":"Clin Orthop Relat Res"},{"key":"1231_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s10038-018-0534-8","volume":"64","author":"H Kobayashi","year":"2019","unstructured":"Kobayashi H (2019) Recent trends in mucopolysaccharidosis research. J Hum Genet 64:127\u2013137. https:\/\/doi.org\/10.1038\/s10038-018-0534-8","journal-title":"J Hum Genet"},{"key":"1231_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/diagnostics10030172","volume":"10","author":"F Kubaski","year":"2020","unstructured":"Kubaski F, de Oliveira PF, Michelin-Tirelli K, Graeff Burin M, Rojas-M\u00e1laga D, Brusius-Facchin AC, Leistner-Segal S, Giugliani R (2020) Diagnosis of Mucopolysaccharidoses. Diagnostics 10:172. https:\/\/doi.org\/10.3390\/diagnostics10030172","journal-title":"Diagnostics"},{"key":"1231_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3390\/ijms24010477","volume":"24","author":"AF Leal","year":"2022","unstructured":"Leal AF, Benincore-Fl\u00f3rez E, Rintz E, Herre\u00f1o-Pach\u00f3n AM, Celik B, Ago Y, Alm\u00e9ciga-D\u00edaz CJ, Tomatsu S (2022) Mucopolysaccharidoses: cellular consequences of glycosaminoglycans accumulation and potential targets. Int J Mol Sci 24:477. https:\/\/doi.org\/10.3390\/ijms24010477","journal-title":"Int J Mol Sci"},{"key":"1231_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1755-8794-6-37","volume":"6","author":"G Mazzoccoli","year":"2013","unstructured":"Mazzoccoli G, Tomanin R, Mazza T, D\u2019Avanzo F, Salvalaio M, Rigon L, Zanetti A, Pazienza V, Francavilla M, Giuliani F, Vinciguerra M, Scarpa M (2013) Circadian transcriptome analysis in human fibroblasts from Hunter syndrome and impact of iduronate-2-sulfatase treatment. BMC Med Genomics 6:37. https:\/\/doi.org\/10.1186\/1755-8794-6-37","journal-title":"BMC Med Genomics"},{"key":"1231_CR21","doi-asserted-by":"publisher","first-page":"dev131110","DOI":"10.1242\/dev.131110","volume":"145","author":"H Miyazawa","year":"2018","unstructured":"Miyazawa H, Aulehla A (2018) Revisiting the role of metabolism during development. Development 145:dev131110. https:\/\/doi.org\/10.1242\/dev.131110","journal-title":"Development"},{"key":"1231_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.prrv.2010.10.005","volume":"12","author":"MS Muhlebach","year":"2011","unstructured":"Muhlebach MS, Wooten W, Muenzer J (2011) Respiratory manifestations in mucopolysaccharidoses. Paedatr Resp Rev 12:133\u2013138. https:\/\/doi.org\/10.1016\/j.prrv.2010.10.005","journal-title":"Paedatr Resp Rev"},{"key":"1231_CR23","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.4103\/ijo.IJO_425_22","volume":"70","author":"R Nagpal","year":"2022","unstructured":"Nagpal R, Goyal RB, Priyadarshini K, Kashyap S, Sharma M, Sinha R, Sharma N (2022) Mucopolysaccharidosis: A broad review. Indian J Ophthalmol 70:2249\u20132261. https:\/\/doi.org\/10.4103\/ijo.IJO_425_22","journal-title":"Indian J Ophthalmol"},{"key":"1231_CR24","doi-asserted-by":"publisher","first-page":"e32419","DOI":"10.1371\/journal.pone.0032419","volume":"7","author":"MK Parente","year":"2012","unstructured":"Parente MK, Rozen R, Cearley CN, Wolfe JH (2012) Dysregulation of gene expression in a lysosomal storage disease varies between brain regions implicating unexpected mechanisms of neuropathology. PloS One 7:e32419. https:\/\/doi.org\/10.1371\/journal.pone.0032419","journal-title":"PloS One"},{"key":"1231_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ymgme.2016.03.003","volume":"118","author":"MK Parente","year":"2016","unstructured":"Parente MK, Rozen R, Seeholzer SH, Wolfe JH (2016) Integrated analysis of proteome and transcriptome changes in the mucopolysaccharidosis type VII mouse hippocampus. Mol Genet Metabol 118:41\u201354. https:\/\/doi.org\/10.1016\/j.ymgme.2016.03.003","journal-title":"Mol Genet Metabol"},{"key":"1231_CR26","doi-asserted-by":"publisher","first-page":"115042","DOI":"10.1016\/j.bone.2019.115042","volume":"128","author":"SH Peck","year":"2019","unstructured":"Peck SH, Tobias JW, Shore EM, Malhotra NR, Haskins ME, Casal ML, Smith LJ (2019) Molecular profiling of failed endochondral ossification in mucopolysaccharidosis VII. Bone 128:115042. https:\/\/doi.org\/10.1016\/j.bone.2019.115042","journal-title":"Bone"},{"issue":"Suppl 1","key":"1231_CR27","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.pedneo.2022.10.001","volume":"64","author":"M Penon-Portmann","year":"2023","unstructured":"Penon-Portmann M, Blair DR, Harmatz P (2023) Current and new therapies for mucopolysaccharidoses. Pediatr Neonatol 64(Suppl 1):S10\u2013S17. https:\/\/doi.org\/10.1016\/j.pedneo.2022.10.001","journal-title":"Pediatr Neonatol"},{"key":"1231_CR28","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3390\/ijms21031156","volume":"21","author":"K Pierzynowska","year":"2020","unstructured":"Pierzynowska K, Gaffke L, Podlacha M, W\u0119grzyn G (2020) Genetic base of behavioral disorders in mucopolysaccharidoses: transcriptomic studies. Int J Mol Sci 21:1156. https:\/\/doi.org\/10.3390\/ijms21031156","journal-title":"Int J Mol Sci"},{"key":"1231_CR29","doi-asserted-by":"publisher","first-page":"151232","DOI":"10.1016\/j.ejcb.2022.151232","volume":"101","author":"K Pierzynowska","year":"2022","unstructured":"Pierzynowska K, \u017babi\u0144ska M, Gaffke L, Cyske Z, W\u0119grzyn G (2022) Changes in expression of signal transduction-related genes, and formation of aggregates of GPER1 and OXTR receptors in mucopolysaccharidosis cells. Eur J Cell Biol 101:151232. https:\/\/doi.org\/10.1016\/j.ejcb.2022.151232","journal-title":"Eur J Cell Biol"},{"key":"1231_CR30","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.3390\/ijms24043887","volume":"24","author":"K Pierzynowska","year":"2023","unstructured":"Pierzynowska K, Gaffke L, \u017babi\u0144ska M, Cyske Z, Rintz E, Wi\u015bniewska K, Podlacha M, W\u0119grzyn G (2023) Roles of the oxytocin receptor (OXTR) in human diseases. Int J Mol Sci 24:3887. https:\/\/doi.org\/10.3390\/ijms24043887","journal-title":"Int J Mol Sci"},{"key":"1231_CR31","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1651-2227.2008.01153.x","volume":"98","author":"E Piotrowska","year":"2009","unstructured":"Piotrowska E, Jak\u00f3bkiewicz-Banecka J, Tylki-Szyma\u0144ska A, Czartoryska B, Wegrzyn A, Wegrzyn G (2009) Correlation between severity of mucopolysaccharidoses and combination of the residual enzyme activity and efficiency of glycosaminoglycan synthesis. Acta Paediatr 98:743\u2013749. https:\/\/doi.org\/10.1111\/j.1651-2227.2008.01153.x","journal-title":"Acta Paediatr"},{"key":"1231_CR32","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.3390\/ijms21093194","volume":"21","author":"E Rintz","year":"2020","unstructured":"Rintz E, Gaffke L, Podlacha M, Brokowska J, Cyske Z, W\u0119grzyn G, Pierzynowska K (2020) Transcriptomic changes related to cellular processes with particular emphasis on cell activation in lysosomal storage diseases from the group of mucopolysaccharidoses. Int J Mol Sci 21:3194. https:\/\/doi.org\/10.3390\/ijms21093194","journal-title":"Int J Mol Sci"},{"key":"1231_CR33","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3390\/ijms18051072","volume":"18","author":"M Salvalaio","year":"2017","unstructured":"Salvalaio M, D\u2019Avanzo F, Rigon L, Zanetti A, D\u2019Angelo M, Valle G, Scarpa M, Tomanin R (2017) Brain RNA-seq profiling of the mucopolysaccharidosis type II mouse model. Int J Mol Sci 18:1072. https:\/\/doi.org\/10.3390\/ijms18051072","journal-title":"Int J Mol Sci"},{"key":"1231_CR34","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/mds.27949","volume":"35","author":"F Sampedro","year":"2020","unstructured":"Sampedro F, Mar\u00edn-Lahoz J, Mart\u00ednez-Horta S, P\u00e9rez-Gonz\u00e1lez R, Pagonabarraga J, Kulisevsky J (2020) CLU rs11136000 promotes early cognitive decline in Parkinson\u2019s disease. Mov Disord 35:508\u2013513. https:\/\/doi.org\/10.1002\/mds.27949","journal-title":"Mov Disord"},{"key":"1231_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ymgme.2019.08.008","volume":"129","author":"JT Saville","year":"2020","unstructured":"Saville JT, Fuller M (2020) Sphingolipid dyshomeostasis in the brain of the mouse model of mucopolysaccharidosis type IIIA. Mol Genet Metabol 129:111\u2013116. https:\/\/doi.org\/10.1016\/j.ymgme.2019.08.008","journal-title":"Mol Genet Metabol"},{"key":"1231_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ymgme.2018.01.003","volume":"125","author":"M Stapleton","year":"2018","unstructured":"Stapleton M, Arunkumar N, Kubaski F, Mason RW, Tadao O, Tomatsu S (2018) Clinical presentation and diagnosis of mucopolysaccharidoses. Mol Genet Metabol 125:4\u201317. https:\/\/doi.org\/10.1016\/j.ymgme.2018.01.003","journal-title":"Mol Genet Metabol"},{"key":"1231_CR37","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1093\/hmg\/ddy259","volume":"27","author":"M Swaroop","year":"2018","unstructured":"Swaroop M, Brooks MJ, Gieser L, Swaroop A, Zheng W (2018) Patient iPSC-derived neural stem cells exhibit phenotypes in concordance with the clinical severity of mucopolysaccharidosis I. Human Mol Genet 27:3612\u20133626. https:\/\/doi.org\/10.1093\/hmg\/ddy259","journal-title":"Human Mol Genet"},{"key":"1231_CR38","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12967-018-1625-1","volume":"16","author":"A Tebani","year":"2018","unstructured":"Tebani A, Abily-Donval L, Schmitz-Afonso I, H\u00e9ron B, Piraud M, Ausseil J, Zerimech F, Gonzalez B, Marret S, Afonso C, Bekri S (2018) Unveiling metabolic remodeling in mucopolysaccharidosis type III through integrative metabolomics and pathway analysis. J Transl Med 16:248. https:\/\/doi.org\/10.1186\/s12967-018-1625-1","journal-title":"J Transl Med"},{"key":"1231_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/14728222.2017.1267142","volume":"21","author":"MR Wilson","year":"2017","unstructured":"Wilson MR, Zoubeidi A (2017) Clusterin as a therapeutic target. Expert Opin Therap Targets 21:201\u2013213. https:\/\/doi.org\/10.1080\/14728222.2017.1267142","journal-title":"Expert Opin Therap Targets"},{"key":"1231_CR40","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s13353-022-00703-1","volume":"63","author":"K Wi\u015bniewska","year":"2022","unstructured":"Wi\u015bniewska K, Wolski J, Gaffke L, Cyske Z, Pierzynowska K, W\u0119grzyn G (2022) Misdiagnosis in mucopolysaccharidoses. J Appl Genet 63:475\u2013495. https:\/\/doi.org\/10.1007\/s13353-022-00703-1","journal-title":"J Appl Genet"},{"key":"1231_CR41","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1042\/BCJ20160998","volume":"474","author":"J Yu","year":"2017","unstructured":"Yu J, Lee CY, Changou CA, Cedano-Prieto DM, Takada YK, Takada Y (2017) The CD9, CD81, and CD151 EC2 domains bind to the classical RGD-binding site of integrin \u03b1v\u03b23. Biochem J 474:589\u2013596. https:\/\/doi.org\/10.1042\/BCJ20160998","journal-title":"Biochem J"},{"key":"1231_CR42","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3390\/pharmaceutics15020704","volume":"15","author":"M \u017babi\u0144ska","year":"2023","unstructured":"\u017babi\u0144ska M, Gaffke L, Biela\u0144ska P, Podlacha M, Rintz E, Cyske Z, W\u0119grzyn G, Pierzynowska K (2023) Decreased levels of chaperones in mucopolysaccharidoses and their elevation as a putative auxiliary therapeutic approach. Pharmaceutics 15:704. https:\/\/doi.org\/10.3390\/pharmaceutics15020704","journal-title":"Pharmaceutics"},{"key":"1231_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-022-00885-2","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Lv X, Chen L, Liu Y (2022) The role and function of CLU in cancer biology and therapy. Clin Exp Med. https:\/\/doi.org\/10.1007\/s10238-022-00885-2. (in Press)","journal-title":"Clin Exp Med"},{"key":"1231_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5582\/irdr.2020.01011","volume":"9","author":"J Zhou","year":"2020","unstructured":"Zhou J, Lin J, Leung WT, Wang L (2020) A basic understanding of mucopolysaccharidosis: Incidence, clinical features, diagnosis, and management. Intractable Rare Dis Res 9:1\u20139. https:\/\/doi.org\/10.5582\/irdr.2020.01011","journal-title":"Intractable Rare Dis Res"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-023-01231-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-023-01231-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-023-01231-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T10:46:31Z","timestamp":1689331591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-023-01231-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,17]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1231"],"URL":"https:\/\/doi.org\/10.1007\/s11011-023-01231-5","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,17]]},"assertion":[{"value":"11 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All ethics-related documents belong to the Coriell Institute from which the cell lines were commercially purchased.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No conflict of interest is declared by the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}